Evaluation of the Consequence of CTNNB1 & amp; RAB1A Targeting on Hepatocellular Carcinoma Cell Line
ConclusionTargetingCTNNB1or RAB1A in HepG2 cell lines decreased the cell viability and proliferative activity. Moreover, targetingCTNNB1 was effective in decreasing cell proliferative activity compared to targetingRAB1A in HepG2 cell lines. So, targeting CTNNB1 may have a potential therapeutic effect in treatment of HCC.
Source: QJM - Category: Internal Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Egypt Health | Genetics | Hepatocellular Carcinoma | Internal Medicine | Liver | Liver Cancer | Liver Disease | Urology & Nephrology